Let’s discuss how to build a compounding pharmacy training program then join me at our roundtables for some fun hands-on aseptic technique training with my fellow sterile compounding experts!
Want to get more out of those expensive reports? Let us show you how.
Pharmacy Technicians continuously evolve by fulfilling the role of the designated person in key areas of the new USP revision.
1) WWDPD & SOPs & USP 797 – say what? 2) Technology – help or hindrance?
Stay ahead of the curve! Equip yourself with principles and practices to thrive in unpredictable sterile compounding environments.
Maintaining a cleanroom requires a lot of moving pieces, meaning a lot can go wrong. You should plan ahead and get organized before disaster hits.
Panel discussion on how using technology has helped leverage systemization in sterile compounding program
Defining work place hazardous is an employee right, having an effective hazardous drug list is the starting point for pharmacies.
Join our panel to discover how techs are excelling as Designated Persons, driving sterile compounding compliance, and leading in pharmacy operations. Let’s redefine the technicians role together.
Standard Operating Procedures (SOPs) are mentioned 57 times in USP 797, and the Designated Person (DP) is required to ensure that SOPs are implemented, staff are proficient, and corrective actions are taken in the event of a problem.
Tuesday morning at NHIA 2025 featured a breakfast symposium covering the clinical management of adverse reactions in immunoglobulin therapy, and our innovative 30-30-30 sessions that cover a central topic from 3 angles with unique perspectives. For example, IV workflow systems were examined from history of their development and use in hospital systems, to their current adoption in home infusion practice, and how to implement such a system if your organization chooses to operationalize one.
Monday morning kicked off with a high-octane networking breakfast before the General Session. We were fortunate to hear from Dr. Mark McClellan, who was FDA Commissioner and CMS Administrator under the George W. Bush administration, who joined NHIA President and CEO Connie Sullivan for a fireside chat.
NHIA 2025 convened the largest gathering dedicated to the home and alternate site infusion industry in Washington, D.C., featuring the event’s most extensive Expo ever with 150 product and service suppliers supporting the industry, including 39 first-time exhibitors. The conference continued to see an increase in individuals investing to attend the conference and nearly 1,600 industry professionals attended the 5-day event.
Let’s discuss how to build a compounding pharmacy training program then join me at our roundtables for some fun hands-on aseptic technique training with my fellow sterile compounding experts!
